Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Ziopharm: Finally A Winner In The War On Cancer?
Seeking Alpha
Mon, 12/16/13 - 08:06 am
Tags:
Ziopharm, cancer, AbbVie, Amgen, Celgene, Celldex Therapeutics, Gilead Sciences, Immunogen, JNJ, ImmunoCellular Therapeutics, Pharmacyclics, Intrexon, Seattle Genetics
AbbVie drug shows promise against difficult type of breast cancer
Reuters
Fri, 12/13/13 - 10:31 am
Tags:
AbbVie, veliparib, triple-negative breast cancer
AbbVie's second PhIII hep C study confirms cocktail's promise
Fierce Biotech
Tue, 12/10/13 - 10:47 am
Tags:
hepatitis C, Enanta Pharmaceuticals, ABT-450, AbbVie
AbbVie leukemia drug impresses in early-stage trial
Reuters
Sun, 12/8/13 - 12:22 pm
Tags:
AbbVie, leukemia, ABT-199
What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs
Seeking Alpha
Fri, 12/6/13 - 10:30 am
Tags:
JNJ, Gilead Sciences, hepatitis C, sofosbuvir, Olysio, AbbVie, Bristol-Myers Squibb, Merck
AIDS Group Sues Abbott And AbbVie Over 340B Drug Discounts
Pharmalot
Mon, 12/2/13 - 11:49 am
Tags:
AIDS, Abbott Labs, 340B, AbbVie
Gilead And AbbVie Battle For Top Spot In $20 Billion Hepatitis Drug Market
Seeking Alpha
Sun, 11/24/13 - 12:24 pm
Tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C, sofosbuvir, ABT-450, ABT-333, ABT-267
New Research And Competition Could Hurt AbbVie's Other Blockbuster
Seeking Alpha
Thu, 11/21/13 - 02:05 pm
Tags:
AbbVie, Auxilium, GSK, Eli Lilly, Androgel
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
Tags:
psoriatic arthritis, Celgene, AbbVie, Amgen, JNJ, Merck, Humira, apremilast, Enbrel, Stelara, Simponi, Remicade
Don't Crown the Hepatitis C Drug Winner Just Yet
Motley Fool
Tue, 11/19/13 - 07:35 am
Tags:
hepatitis C, Gilead Sciences, ABT-333, Ribavirin, ABT-450, ritonavir, ABT-267, AbbVie
AbbVie steps closer to FDA filing as first hep C PhIII delivers promising results
Fierce Biotech
Mon, 11/18/13 - 10:04 am
Tags:
sofosbuvir, FDA, AbbVie, hepatitis C
Why Big Pharma Is Breaking Up
Motley Fool
Wed, 11/13/13 - 08:29 am
Tags:
Merck, Novartis, Big Pharma, Abbott Labs, AbbVie, Pfizer, Zoetis
AbbVie's Not as Vulnerable as the Street Believes
TheStreet.com
Fri, 11/8/13 - 09:07 am
Tags:
AbbVie
Gilead Vs. Challengers In The Hepatitis C Race
Seeking Alpha
Thu, 11/7/13 - 09:52 am
Tags:
Gilead, hepatitis C, AbbVie, Bristol-Myers Squibb, JNJ, Merck, simeprevir, sofosbuvir, daclatasvir
Analyst ranks the top 11 pharma giants' prospects, putting GSK on top
Fierce Biotech
Wed, 11/6/13 - 10:39 am
Tags:
GSK, Bayer, Sanofi, Novartis, JNJ, Bristol-Myers Squibb, Merck, AbbVie, Eli Lilly, Pfizer, AstraZeneca
Testosterone Drugs Raise Heart Risk in $1 Billion Market
Bloomberg
Wed, 11/6/13 - 08:34 am
Tags:
testosterone, Eli Lilly, Actavis, Androgel, Axiron, AbbVie, Androderm
We Like What We're Seeing In Big Pharma
Seeking Alpha
Tue, 11/5/13 - 08:42 am
Tags:
Bristol-Myers Squibb, AbbVie, Eli Lilly
Bristol-Myers Vs. Abbvie In Potential Humira Rivalry
Seeking Alpha
Mon, 11/4/13 - 09:47 am
Tags:
AbbVie, Humira, Bristol-Myers Squibb, clazakizumab
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
Tags:
patents, Copaxone, Teva, Nexium, AstraZeneca, Micardis, Boehringer Ingelheim, Sandostatin LAR, Novartis, Exforge, Nasonex, Merck, TriLipix, AbbVie, Evista, Eli Lilly, Restasis, Allergan, Renagel, Sanofi
Can Merck's Breadth Beat AbbVie's and Pfizer's Focus?
Motley Fool
Fri, 10/25/13 - 11:32 am
Tags:
Merck, Pfizer, AbbVie

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.